Our successes
As well as providing genomic testing for the North Thames region, we are accelerating the pace at which genomics is embedded in everyday healthcare care through our transformation projects and research.
The ctDNA pilot project
In 2022 NHS England (NHSE) commissioned a pilot study to evaluate how ctDNA testing could be integrated into the standard NHS lung cancer pathway and the impact it would have on patients.
The three-phased pilot was led by the North Thames and North-East and Yorkshire GMSA.
100,000 Genomes project
The NHS North Thames GMS is building on the foundations of the 100,000 Genomes project driving forward its aim to make genomics part of routine healthcare. We work closely with NHS, academic and commercial partners to support, promote and conduct research and transformation projects which will bring the benefits of genomics to patients and their families.
Our approach to research and transformation is broad and encompasses the development and implementation of new tests, technologies and service pathways as well as clinical, translational and basic research.
Transformation projects
We support a range of transformation projects across disease areas including cancer, rare diseases, personalised medicine and primary care.
We focus on delivering projects which enable equity of access for patients across the North Thames region, transform clinical care or NHS services and have a direct impact to patients and service users.
Many of the projects we support are submitted to and approved by NHSE for transformation funding, based on key national priorities. In addition to providing allocated funding to projects, we also provide support in other ways, such as programme management, helping create partnership networks and providing education and communications support.
